BioElectronics Corp/ US09062H1086 /
2024-04-17 9:21:57 PM | Chg. -0.0001 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.0002USD | -33.33% | 6.63 mill. Turnover: 1,336.0684 |
-Bid Size: - | -Ask Size: - | 0.0003 | 0.0001 |
GlobeNewswire
03-25
BioElectronics Corporation Announces the Publication of a Canine Arthritis Study
GlobeNewswire
02-02
Pixium Vision announces the rejection of the sale plan (plan de cession) by the Court and the conver...
GlobeNewswire
01-18
NeuroSigma Announces FDA Clearance of its Second-Generation Monarch eTNS System for Treating Pediatr...
GlobeNewswire
01-17
Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of jud...
GlobeNewswire
01-17
Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of jud...
GlobeNewswire
2023-12-18
Decision concerning the adoption of a sale plan (plan de cession) and the opening of judicial liquid...
GlobeNewswire
2023-12-04
Commercial Court hearing to examine the takeover offer scheduled for December 18, 2023
GlobeNewswire
2023-11-20
Update on the receivership proceedings: submission of a takeover offer to the court-appointed admini...
GlobeNewswire
2023-11-13
Pixium Vision announces the conversion of the safeguard proceedings into receivership
GlobeNewswire
2023-11-07
NeuroSigma Announces FDA 510(k) Submission for Second Generation Monarch eTNS System
GlobeNewswire
2023-10-26
Pixium Vision announces its financial results for H1 2023 and provides update
GlobeNewswire
2023-09-20
Pixium Vision announces the completion of the reverse stock split of its shares on the basis of 1 ne...
GlobeNewswire
2022-03-29
Pixium Vision announces FDA approval of clinical trial expansion of Prima System US feasibility stud...
GlobeNewswire
2022-03-24
Pixium Vision to participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and ...
GlobeNewswire
2022-03-14
Pixium Vision convenes a Combined General Meeting of Shareholders on April 19, 2022
GlobeNewswire
2022-02-28
BioElectronics Corporation Chairman Richard Staelin, Ph.D., Updates Company Achievements